1,2-dichloroethane decreases expression ISO RGD:1314506 6480464 ethylene dichloride results in decreased expression of PYHIN1 mRNA CTD PMID:28960355 1,2-dichloroethane decreases expression ISO RGD:1557521 6480464 ethylene dichloride results in decreased expression of IFI204 mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:1557521 6480464 1, 2-Dimethylhydrazine results in increased expression of IFI204 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1557521 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IFI204 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of IFI204 mRNA CTD PMID:25380136 17beta-estradiol increases expression ISO RGD:1557521 6480464 Estradiol results in increased expression of IFI204 mRNA CTD PMID:19484750 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MNDA mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate increases expression EXP 6480464 estradiol 3-benzoate results in increased expression of MNDA mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MNDA mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1314506 6480464 Tetrachlorodibenzodioxin affects the expression of PYHIN1 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MNDA mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MNDA mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1314506 6480464 Tetrachlorodibenzodioxin results in increased expression of MNDA mRNA CTD PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1557521 6480464 Tetrachlorodibenzodioxin results in increased expression of IFI204 mRNA CTD PMID:21041162 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1557521 6480464 Trinitrobenzenesulfonic Acid results in increased expression of IFI204 mRNA CTD PMID:17982090 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1314506 6480464 Trinitrobenzenesulfonic Acid results in increased expression of MNDA mRNA CTD PMID:17982090 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:1557521 6480464 Glucosamine results in increased expression of IFI204 mRNA CTD PMID:17178593 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1557521 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IFI204 mRNA CTD PMID:16054899 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of IFI204 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane affects expression ISO RGD:1557521 6480464 4, 4'-diaminodiphenylmethane affects the expression of IFI16 mRNA CTD PMID:18648102 4-hydroxynon-2-enal decreases expression ISO RGD:1557521 6480464 4-hydroxy-2-nonenal results in decreased expression of IFI16 mRNA, 4-hydroxy-2-nonenal results in decreased expression of IFI204 mRNA CTD PMID:19191707 4-hydroxynon-2-enal decreases expression ISO RGD:1314505 6480464 4-hydroxy-2-nonenal results in decreased expression of MNDA mRNA CTD PMID:12419474 4-hydroxyphenyl retinamide decreases expression ISO RGD:1557521 6480464 Fenretinide results in decreased expression of IFI16 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression ISO RGD:1557521 6480464 Fenretinide results in increased expression of IFI16 mRNA, Fenretinide results in increased expression of IFI204 mRNA CTD PMID:16467112 , PMID:28973697 acetamide increases expression EXP 6480464 acetamide results in increased expression of MNDA mRNA CTD PMID:31881176 aldehydo-D-glucosamine increases expression ISO RGD:1557521 6480464 Glucosamine results in increased expression of IFI204 mRNA CTD PMID:17178593 all-trans-retinoic acid increases expression ISO RGD:1314505 6480464 Tretinoin results in increased expression of MNDA mRNA CTD PMID:17218384 , PMID:33167477 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of IFI204 mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:1314505 6480464 Antirheumatic Agents results in decreased expression of MNDA mRNA CTD PMID:24449571 benzo[a]pyrene decreases expression ISO RGD:1314506 6480464 Benzo(a)pyrene results in decreased expression of PYHIN1 mRNA CTD PMID:21569818 benzo[a]pyrene decreases expression ISO RGD:1314505 6480464 Benzo(a)pyrene results in decreased expression of MNDA mRNA CTD PMID:20064835 benzo[b]fluoranthene increases expression ISO RGD:1314506 6480464 benzo(b)fluoranthene results in increased expression of PYHIN1 mRNA CTD PMID:26377693 beta-D-glucosamine increases expression ISO RGD:1557521 6480464 Glucosamine results in increased expression of IFI204 mRNA CTD PMID:17178593 bis(2-chloroethyl) sulfide increases expression ISO RGD:1557521 6480464 Mustard Gas results in increased expression of IFI204 mRNA CTD PMID:15674844 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MNDA mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1557521 6480464 bisphenol A results in decreased expression of IFI204 mRNA CTD PMID:33221593 buta-1,3-diene decreases expression ISO RGD:1314506 6480464 1, 3-butadiene results in decreased expression of PYHIN1 mRNA CTD PMID:29038090 cadmium atom multiple interactions ISO RGD:1314505 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MNDA mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1314505 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MNDA mRNA CTD PMID:35301059 caffeine increases phosphorylation ISO RGD:1314505 6480464 Caffeine results in increased phosphorylation of MNDA protein CTD PMID:35688186 carbon nanotube affects expression ISO RGD:1314506 6480464 Nanotubes, Carbon analog affects the expression of PYHIN1 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1557521 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1314506 6480464 Nanotubes, Carbon analog results in decreased expression of MNDA mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:1314506 6480464 Nanotubes more ... CTD PMID:25554681 chlordecone multiple interactions ISO RGD:1557521 6480464 Chlordecone promotes the reaction [Biomarkers metabolite binds to IFI204 gene] CTD PMID:31084621 chlordecone multiple interactions ISO RGD:1314506 6480464 Chlordecone promotes the reaction [Biomarkers metabolite binds to MNDA gene] CTD PMID:31084621 chloroprene decreases expression ISO RGD:1314506 6480464 Chloroprene results in decreased expression of PYHIN1 mRNA CTD PMID:23125180 chlorpyrifos increases expression ISO RGD:1557521 6480464 Chlorpyrifos results in increased expression of IFI204 mRNA CTD PMID:32715474 cisplatin increases expression ISO RGD:1557521 6480464 Cisplatin results in increased expression of IFI16 mRNA CTD PMID:21151649 clofibrate multiple interactions ISO RGD:1314506 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MNDA mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MNDA mRNA] CTD PMID:17585979 copper atom decreases expression EXP 6480464 Copper results in decreased expression of IFI204 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of IFI204 mRNA CTD PMID:30556269 cyclophosphamide increases expression ISO RGD:1557521 6480464 Cyclophosphamide results in increased expression of IFI204 mRNA CTD PMID:21041162 dexamethasone multiple interactions ISO RGD:1557521 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IFI204 mRNA CTD PMID:16054899 dexamethasone increases expression ISO RGD:1557521 6480464 Dexamethasone results in increased expression of IFI204 mRNA CTD PMID:21041162 dextran sulfate increases expression ISO RGD:1314506 6480464 Dextran Sulfate results in increased expression of PYHIN1 mRNA CTD PMID:23894361 dextran sulfate multiple interactions ISO RGD:1557521 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IFI204 mRNA CTD PMID:29950665 dichlorine increases expression ISO RGD:1557521 6480464 Chlorine results in increased expression of IFI204 mRNA CTD PMID:30189237 diclofenac increases expression ISO RGD:1314506 6480464 Diclofenac results in increased expression of MNDA mRNA CTD PMID:26934552 diethylstilbestrol increases expression ISO RGD:1557521 6480464 Diethylstilbestrol results in increased expression of IFI204 mRNA CTD PMID:21041162 dioxygen multiple interactions ISO RGD:1314506 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PYHIN1 mRNA CTD PMID:30529165 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MNDA mRNA CTD PMID:29391264 epoxiconazole increases expression ISO RGD:1314506 6480464 epoxiconazole results in increased expression of IFI211 mRNA CTD PMID:35436446 fluoranthene multiple interactions ISO RGD:1557521 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of IFI204 mRNA CTD PMID:28329830 fluoranthene multiple interactions ISO RGD:1314506 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of MNDA mRNA CTD PMID:28329830 folic acid affects expression ISO RGD:1557521 6480464 Folic Acid deficiency affects the expression of IFI204 mRNA CTD PMID:32304770 folic acid multiple interactions ISO RGD:1557521 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IFI204 mRNA CTD PMID:22206623 furan increases expression EXP 6480464 furan results in increased expression of IFI204 mRNA CTD PMID:27387713 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MNDA mRNA CTD PMID:22061828 , PMID:33387578 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:1314506 6480464 indeno(1 more ... CTD PMID:26377693 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of IFI204 mRNA CTD PMID:21396975 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of PYHIN1 mRNA CTD PMID:35283115 lipopolysaccharide affects expression ISO RGD:1557521 6480464 Lipopolysaccharides affects the expression of IFI204 mRNA CTD PMID:24056979 lipopolysaccharide multiple interactions ISO RGD:1314505 6480464 [S-(1 more ... CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:1557521 6480464 methyldithiocarbamate inhibits the reaction [Lipopolysaccharides affects the expression of IFI204 mRNA] CTD PMID:24056979 lipopolysaccharide increases expression ISO RGD:1557521 6480464 Lipopolysaccharides results in increased expression of IFI204 mRNA CTD PMID:25890327 , PMID:26582142 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of IFI204 mRNA CTD PMID:28801915 metam multiple interactions ISO RGD:1557521 6480464 methyldithiocarbamate inhibits the reaction [Lipopolysaccharides affects the expression of IFI204 mRNA] CTD PMID:24056979 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of IFI204 mRNA CTD PMID:25380136 nickel atom decreases expression ISO RGD:1314505 6480464 Nickel results in decreased expression of MNDA mRNA CTD PMID:23195993 nickel atom increases expression ISO RGD:1314505 6480464 Nickel results in increased expression of MNDA mRNA CTD PMID:24768652 , PMID:25583101 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of MNDA mRNA CTD PMID:33484710 nonanoic acid increases expression ISO RGD:1557521 6480464 pelargonic acid results in increased expression of IFI204 mRNA CTD PMID:11379042 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of MNDA mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MNDA mRNA CTD PMID:25729387 ozone decreases expression ISO RGD:1314506 6480464 Ozone results in decreased expression of MNDA mRNA CTD PMID:16183385 ozone multiple interactions ISO RGD:1557521 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of IFI204 mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:1557521 6480464 Acetaminophen affects the expression of IFI204 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of MNDA mRNA CTD PMID:33387578 paracetamol multiple interactions ISO RGD:1314506 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MNDA mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MNDA mRNA] CTD PMID:17585979 paraquat increases expression EXP 6480464 Paraquat results in increased expression of MNDA mRNA CTD PMID:32680482 pentachlorophenol increases expression ISO RGD:1314506 6480464 Pentachlorophenol results in increased expression of PYHIN1 mRNA CTD PMID:23892564 pentachlorophenol increases expression ISO RGD:1557521 6480464 Pentachlorophenol results in increased expression of IFI204 mRNA CTD PMID:23892564 perfluorooctanoic acid increases expression ISO RGD:1314506 6480464 perfluorooctanoic acid results in increased expression of IFI211 mRNA CTD PMID:30711707 pirinixic acid decreases expression ISO RGD:1557521 6480464 pirinixic acid results in decreased expression of IFI204 mRNA CTD PMID:18445702 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1314505 6480464 [S-(1 more ... CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1314505 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of MNDA mRNA CTD PMID:35811015 serpentine asbestos decreases expression ISO RGD:1314505 6480464 Asbestos, Serpentine results in decreased expression of MNDA mRNA CTD PMID:21148743 silicon dioxide increases expression ISO RGD:1314506 6480464 Silicon Dioxide results in increased expression of MNDA mRNA CTD PMID:29341224 silicon dioxide increases expression ISO RGD:1557521 6480464 Silicon Dioxide results in increased expression of IFI204 mRNA CTD PMID:29341224 silver atom affects expression ISO RGD:1314506 6480464 Silver affects the expression of PYHIN1 mRNA CTD PMID:27131904 silver atom decreases expression ISO RGD:1557521 6480464 Silver results in decreased expression of IFI204 mRNA CTD PMID:27131904 silver(0) affects expression ISO RGD:1314506 6480464 Silver affects the expression of PYHIN1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1557521 6480464 Silver results in decreased expression of IFI204 mRNA CTD PMID:27131904 succimer multiple interactions ISO RGD:1314506 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MNDA mRNA CTD PMID:21641980 sulforaphane increases expression ISO RGD:1314505 6480464 sulforaphane results in increased expression of MNDA mRNA CTD PMID:26833863 tamoxifen affects expression ISO RGD:1314506 6480464 Tamoxifen affects the expression of PYHIN1 mRNA CTD PMID:20937368 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MNDA mRNA CTD PMID:32741896 tetrachloromethane affects expression ISO RGD:1557521 6480464 Carbon Tetrachloride affects the expression of IFI204 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:1557521 6480464 Carbon Tetrachloride results in increased expression of IFI204 mRNA CTD PMID:29987408 , PMID:31919559 tetrachloromethane increases expression ISO RGD:1314506 6480464 Carbon Tetrachloride results in increased expression of PYHIN1 mRNA CTD PMID:27339419 tetraphene decreases expression ISO RGD:1314506 6480464 benz(a)anthracene results in decreased expression of MNDA mRNA CTD PMID:26377693 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MNDA mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1557521 6480464 titanium dioxide results in increased expression of IFI204 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:1557521 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IFI204 mRNA CTD PMID:29950665 titanium dioxide increases expression ISO RGD:1314506 6480464 titanium dioxide results in increased expression of IFI211 mRNA, titanium dioxide results in increased expression of PYHIN1 mRNA CTD PMID:23557971 , PMID:27760801 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MNDA mRNA CTD PMID:25729387 tremolite asbestos increases expression ISO RGD:1314506 6480464 tremolite results in increased expression of IFI211 mRNA CTD PMID:29279043 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of MNDA mRNA CTD PMID:33387578 trovafloxacin increases expression ISO RGD:1314506 6480464 trovafloxacin results in increased expression of MNDA mRNA, trovafloxacin results in increased expression of PYHIN1 mRNA CTD PMID:35537566 valproic acid affects expression ISO RGD:1557521 6480464 Valproic Acid affects the expression of IFI16 mRNA CTD PMID:17292431 zidovudine multiple interactions ISO RGD:1314505 6480464 [Zidovudine co-treated with IFNA1 protein] results in increased expression of MNDA mRNA CTD PMID:20370541